Last reviewed · How we verify

An Open Label Crossover Study In Healthy Older Male Subjects To Evaluate The Pharmacokinetics And Safety Of Sildenafil Following Fasted Administration Of An Orally Disintegrating Tablet Formulation Of Sildenafil Administered With Or Without Water Relative To Viagra® Oral Tablet With Water

NCT01254383 Phase 1 COMPLETED

This study will evaluate if an orally disintegrating tablet of sildenafil will have similar pharmacokinetic properties as the conventional tablet of sildenafil.

Details

Lead sponsorPfizer's Upjohn has merged with Mylan to form Viatris Inc.
PhasePhase 1
StatusCOMPLETED
Enrolment36
Start date2010-12
Completion2011-03

Conditions

Interventions

Primary outcomes

Countries

Singapore